Form Approved
OMB Control No.: 0920-1310
Expiration date: XX/XX/XXXX
ARLN Alert Form
Submitting State Laboratory ID |
Date alert sent from jurisdiction to CDC |
Which state is submitting this alert? |
From which state did the isolate originate? |
Alert type |
Alert type other, specify |
Was this pan resistant? (non-susceptible to all drugs tested thus far) |
Was this isolate sent to regional laboratory for testing? |
Original submitting State Laboratory ID |
Specimen source |
Patient age in years |
Date of specimen collection |
Organism (Genera) |
Other genus, specify |
Species |
mCIM or Carba-NP results? |
KPC Result |
NDM Result |
OXA-48 Result |
OXA-23, -24/40, 58-like Result |
VIM Result |
IMP Result |
Which method(s) was used to test IMP? |
By which method was IMP positive? |
mcr-1 Result |
mcr-2 Result |
Other genes detected |
Other genes detected, specify |
Description of AST for the isolate? |
AST file from submitting lab |
AST from submitting clinical lab |
AST from public health lab |
Which method was used to conduct AST at Public Health Laboratory? |
AST result for Amikacin |
AST result for Ticarcillin/clavulanic acid constant 2 |
AST result for Aztreonam |
AST result for Cefepime |
AST result for Piperacillin/tazobactam constant 4 |
AST result for Trimethoprim/sulfamethoxazole |
AST result for Gentamicin |
AST result for Cefepime |
AST result for Tobramycin |
AST result for Levofloxacin |
AST result for Doxycycline |
AST result for Ciprofloxacin |
AST result for Minocycline |
AST result for Meropenem |
AST result for Doripenem |
AST result for Colistin |
AST result for Polymixin B |
AST result for Ceftazidime |
AST result for Cefotaxime |
AST result for Tigecycline |
AST result for Ertapenem |
AST result for Imipenem |
AST result for Cefazolin |
AST result for Ceftriaxone |
AST result for Amoxicillin/Clavulanic acid |
AST result for Ampicillin |
AST result for Ampicillin/Sulbactam |
AST result for Nitrofurantoin |
AST result for Ceftazidime Avibactam |
AST result for Ceftolozane/tazobactam |
AST result for Moxifloxacin |
AST results from Regional lab |
Was the specimen detected during colonization screening? |
State lab ID of the Index patient (isolate) |
Any other information about the isolate/patient you would like to us to know? |
Public reporting burden of this collection of information is estimated to average 6 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA 0920-1310
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Gilbert, Sarah (CDC/DDID/NCEZID/DHQP) (CTR) |
File Modified | 0000-00-00 |
File Created | 2023-08-29 |